Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission

Overview of attention for article published in OncoTargets and therapy, June 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,763 followers.

Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission. by Zhou M, Wang J, Li CP, Xu JY, Chen B https://t.co/qBab9xIRit

02 Jul 2020

Reply Repost Favourite

Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission. #lymphoma #lymsm https://t.co/1UbzqFgvV2

02 Jul 2020

Reply Repost Favourite

New article: Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission. https://t.co/3cKH27VjB6 #DLBCL #lymsm #hematology https://t.co/hFOStSJu4Z

02 Jul 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission

About this Attention Score

Mentioned by

Citations

Readers on